Myocarditis in COVID-19 patients: current problems

Donato Mele1, Filippo Flamigni1, Claudio Rapezzi1, Roberto Ferrari1
1Cardiology Center, University of Ferrara, Viale Aldo Moro 8, 44024, Cona, Ferrara, Italy

Tóm tắt

Từ khóa


Tài liệu tham khảo

Chen N, Zhou M, Dong X et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507–513

Hendren NS, Drazner MH, Bozkurt B, Cooper LT Jr (2020) Description and proposed management of the acute COVID-19 cardiovascular syndrome. Circulation 141:1903–1914

Ali-Ahmed F, Dalgaard F, Al-Khatib SM (2020) Sudden cardiac death in patients with myocarditis: evaluation, risk stratification, and management. Am Heart J 220:29–40

https://www.nytimes.com/2020/03/27/health/coronavirus-cardiac-heart-attacks.html

Caforio ALP, Pankuweit S, Arbustini E et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648

Ferreira VM, Schulz-Menger J, Holmvang G et al (2018) Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert reccomendations. J Am CollCardiol 24:3158–3176

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR et al (2019) Fourth universal definition of myocardial infarction. Eur Heart J 40:237–269

Leone O, Pieroni M, Rapezzi C, Olivotto I (2019) The spectrum of myocarditis: from pathology to the clinics. Virchows Arch 475:279–301

Cooper LT, Baughman KL, Feldman AM et al (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216–2233

D’Andrea A, Di Giannuario G, Marrazzo G et al (2020) The role of multimodality imaging in COVID-19 patients: from diagnosis to clinical monitoring and prognosis. G Ital Cardiol 21:345–353

Bonow RO, Fonarrow GC, O’Gara PT, Yancy CW (2020) Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol 5:751–753

Yang X, Yu Y, Xu J et al (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8:475–481

Shi S, Qin M, Shen B et al (2020) Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan. China JAMA Cardiol 5:802–810

Zhou F, Yu T, Du R et al (2020) Clinical Course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395:1054–1062

Sawalha K, Abozenah M, Kadado AJ et al (2020) Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovasc Revasc Med. https://doi.org/10.1016/j.carrev.2020.08.028

Kariyanna PT, Sutarjono B, Grewal E et al (2020) A systematic review of COVID-19 and myocarditis. Am J Med Case Rep 8:299–305

Ho JS, Sia CH, Chan MY, Lin W, Wong RC (2020) Coronavirus-induced myocarditis: a meta-summary of cases. Heart Lung 49:681–685

Esposito A, Palmisano A, Natale L et al (2020) Cardiac magnetic resonance characterization of myocarditis-like acute cardiac syndrome in COVID-19. JACC Cardiovasc Imaging 13:2462–2465

Mele D, D’Andrea A, Campana M et al (2020) Non-ischemic ventricular dysfunction in COVID-19 patients: characteristics and implications for cardiac imaging on the basis of current evidence. G Ital Cardiol 21:739–749

Khatri A, Wallach F (2020) Coronavirus disease 2019 (Covid-19) presenting as purulent fulminant myopericarditis and cardiac tamponade: a case report and literature review. Heart Lung 49:858–863

Ozieranski K, Tyminska A, Jonik S et al (2020) Clinically suspected myocarditis in the course of severe acute respiratory syndrome novel coronavirus-2 infection: fact or fiction? J Cardiac Fail. https://doi.org/10.1016/j.cardfail.2020.11.002

Sala S, Peretto G, Gramegna M et al (2020) Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J 41:1861–1862

Tavazzi G, Pellegrini C, Maurelli M et al (2020) Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail 22:911–915

Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. Intensive Care Med 46:846–848

Zeng J-H, Liu Y-X, Yuan J et al (2020) First case of COVID-19 complicated with fulminant myocarditis: a case report and insights. Infection 48:773–777

Shchedrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S (2020) COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. https://doi.org/10.1080/14779072.2021.1844005

Escher F, Pietsch H, Aleshcheva G et al (2020) Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Failure 7:2440–2447

Basso C, Leone O, Rizzo S et al (2020) Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J 41:3827–3835

Lindner D, Fitzek A, Bräuninger H et al (2020) Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol 5:1281–1285

Wichmann D, Sperhake J-P, Lutgehetmann M et al (2020) Autopsy findings and venous thromboembolism in patients with COVID-19 a prospective cohort study. Ann Intern Med. https://doi.org/10.7326/M20-2003

Buja LM, Wolf DA, Zhao B et al (2020) The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovascular Pathology 48:107233

Fox SE, Akmatbekov A, Harbert JL et al (2020) Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans. Lancet Respir Med 8:681–686

Menter T, Haslbauer JD, Nienhold R et al (2020) Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology 77:198–209

Craver R, Huber S, Sandomirsky M et al (2020) Fatal eosinophilic myocarditis in a healthy 17-year-old male with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2c). Fetal Pediatr Pathol 39:263–268

Russell B, Moss C, George G et al (2020) Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. Ecancermedicalscience 14:1022

Alijotas-Reiga J, Esteve-Valverde E, Beliznaf C et al (2020) Immunomodulatory therapy for the management of severe COVID-Beyond the anti-viral therapy: a comprehensive review. Autoimmunity Rev 19:102569

Varga Z, Flammer AJ, Steiger P et al (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395:1417–1418

Cooper LT, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis–natural history and treatment. Multicenter giant cell myocarditis study group investigators. N Engl J Med 336:1860–1866

Cooper LT Jr, Hare JM, Tazelaar HD et al (2008) Giant cell myocarditis treatment trial investigators usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102:1535–1539

Frustaci A, Chimenti C, Calabrese F et al (2003) Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 107:857–863

Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:1995–2002

Mason JW, Billingham ME, Ricci DR (1980) Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. Am J Cardiol 45:1037–1044

Jones SR, Herskowitz A, Hutchins GM, Baughman KL (1991) Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function. Am J Cardiol 68:370–376

Kociol RD, Cooper LT, Fang JC et al (2020) Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation 141:e69–e92

Mehta P, McAuley DF, Brown M et al (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395:1033–1034

Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern Med 180:934–943

Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395:473–475

Huang X, Sun Y, Su G, Li Y, Shuai X (2019) Intravenous immunoglobulin therapy for acute myocarditis in children and adults. Int Heart J 60:359–365

Shen C, Wang Z, Zhao F et al (2020) Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma. JAMA 323:1582–1589

Kow CS, Hasan SS (2020) Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection 48:805–806

WHO Solidarity Trial Consortium (2020) Repurposed antiviral drugs for COVID-19—interim WHO solidarity trial results. N Engl J Med. https://doi.org/10.1056/NEJMoa2023184

Recovery Collaborative Group (2020) Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, plat-form trial. Lancet 396:1345–1352

Xu Z, Shi L, Wang Y et al (2020) Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 8:420–422

Evans PC, Rainger GE, Mason JC et al (2020) Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res 116:2177–2184

Siripanthong B, Nazarian S, Muser D et al (2020) Recognizing COVID-19—related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 17:1463–1471

Cau R, Bassareo P, Saba L (2020) Cardiac involvement in COVID-19—assessment with echocardiography and cardiac magnetic resonance imaging. SN Compr Clin Med. https://doi.org/10.1007/s42399-020-00344-7